147 related articles for article (PubMed ID: 8770721)
1. Cost of hypertension treatment.
Odell TW; Gregory MC
J Gen Intern Med; 1995 Dec; 10(12):686-8. PubMed ID: 8770721
[TBL] [Abstract][Full Text] [Related]
2. The cost of treating high blood pressure in general practice in France.
Tibi-Levy Y; de Pouvourville G; Westerloppe J; Bamberger M
Eur J Health Econ; 2008 Aug; 9(3):229-36. PubMed ID: 17566802
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the total cost of treating elderly hypertensive patients with ACE inhibitors: a comparison of older and newer agents.
Small RE; Freeman-Arnold SB; Goode JV; Pyles MA
Pharmacotherapy; 1997; 17(5):1011-6. PubMed ID: 9324190
[TBL] [Abstract][Full Text] [Related]
4. Economic evaluation of home blood pressure telemonitoring: a randomized controlled trial.
Madsen LB; Christiansen T; Kirkegaard P; Pedersen EB
Blood Press; 2011 Apr; 20(2):117-25. PubMed ID: 21105759
[TBL] [Abstract][Full Text] [Related]
5. Can the cost of care be contained and quality of care maintained in the management of hypertension?
Moser M
Arch Intern Med; 1994 Aug; 154(15):1665-72. PubMed ID: 8042883
[No Abstract] [Full Text] [Related]
6. The financial cost of optimising blood pressure control.
Shiner T; Simons L; Parkinson H; Khanbhai A; Karthikeyan VJ; Nandhara G; Beevers DG
J Hum Hypertens; 2005 Jan; 19(1):83-4. PubMed ID: 15372065
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic and economic controversies in antihypertensive therapy.
McCarron DA; Hare LE; Walker BR
J Cardiovasc Pharmacol; 1984; 6 Suppl 5():S837-40. PubMed ID: 6084136
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin receptor blockers: impact on costs of care.
Am J Manag Care; 2005 Nov; 11(13 Suppl):S400-3. PubMed ID: 16300456
[TBL] [Abstract][Full Text] [Related]
9. [Relationship of polymedication in controlling blood pressure: compliance, persistence, costs and incidence of new cardiovascular events].
Sicras Mainar A; Muñoz Ortí G; Font Ramos B; Majós Oró N; Navarro Artieda R; Ibáñez Nolla J
Med Clin (Barc); 2013 Jul; 141(2):53-61. PubMed ID: 22766057
[TBL] [Abstract][Full Text] [Related]
10. [The pharmaco-economics of the treatment of arterial hypertension: data and controversies].
Rorive G; Delporte JP
Bull Mem Acad R Med Belg; 1998; 153(7-9):317-21; discussion 322-4. PubMed ID: 10100395
[TBL] [Abstract][Full Text] [Related]
11. A retrospective analysis comparing the costs and cost effectiveness of amlodipine and enalapril in the treatment of hypertension.
Doyle J; Omvik P; Arikian S; Casciano J; Casciano R; Gonzalez MA; Arocho R
Manag Care Interface; 2001 Mar; 14(3):82-7. PubMed ID: 11301961
[TBL] [Abstract][Full Text] [Related]
12. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care.
Mazzaglia G; Mantovani LG; Sturkenboom MC; Filippi A; Trifirò G; Cricelli C; Brignoli O; Caputi AP
J Hypertens; 2005 Nov; 23(11):2093-100. PubMed ID: 16208153
[TBL] [Abstract][Full Text] [Related]
13. [Medical economics of hypertension therapy].
Yamazaki T
Nihon Rinsho; 2008 Aug; 66(8):1601-4. PubMed ID: 18700564
[No Abstract] [Full Text] [Related]
14. Cost-effectiveness of antihypertensive treatment in patients 80 years of age or older in Switzerland: an analysis of the HYVET study from a Swiss perspective.
Szucs TD; Waeber B; Tomonaga Y
J Hum Hypertens; 2010 Feb; 24(2):117-23. PubMed ID: 19536166
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of hypertension treatment.
Ménard J
Clin Exp Hypertens; 1996; 18(3-4):399-413. PubMed ID: 8743030
[TBL] [Abstract][Full Text] [Related]
16. Cost estimation of hypertension management based on home blood pressure monitoring alone or combined office and ambulatory blood pressure measurements.
Boubouchairopoulou N; Karpettas N; Athanasakis K; Kollias A; Protogerou AD; Achimastos A; Stergiou GS
J Am Soc Hypertens; 2014 Oct; 8(10):732-8. PubMed ID: 25418495
[TBL] [Abstract][Full Text] [Related]
17. Cost-minimization analysis of initial antihypertensive therapy in patients with mild-to-moderate essential diastolic hypertension.
Hilleman DE; Mohiuddin SM; Lucas BD; Stading JA; Stoysich AM; Ryschon K
Clin Ther; 1994; 16(1):88-102; discussion 87. PubMed ID: 7911403
[TBL] [Abstract][Full Text] [Related]
18. An economic evaluation of the JNC hypertension guidelines using data from a randomized controlled trial. Joint National Committee.
Ramsey SD; Neil N; Sullivan SD; Perfetto E
J Am Board Fam Pract; 1999; 12(2):105-14. PubMed ID: 10220232
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive treatment based on blood pressure measurement at home or in the physician's office: a randomized controlled trial.
Staessen JA; Den Hond E; Celis H; Fagard R; Keary L; Vandenhoven G; O'Brien ET;
JAMA; 2004 Feb; 291(8):955-64. PubMed ID: 14982911
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacotherapy of hypertension. How much can safely be saved?].
Anlauf M
MMW Fortschr Med; 2004 Apr; 146(15):57-8. PubMed ID: 15373022
[No Abstract] [Full Text] [Related]
[Next] [New Search]